Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...

WeightWatchers has appointed Dr. Kim Boyd as chief medical officer and announced a new program focused on helping women ...

Walmart Inc. is giving $500,000 in grants and in-kind donations to Central Texas communities hit over the July Fourth weekend ...

In December, GLP-1 agonist tirzepatide (Zepbound) became the first drug approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity after two trials showed it reduced ...

Zepbound is a medication containing tirzepatide, which the preliminary study showed to be more effective for weight loss than Wegovy, which contains semaglutide.

FICO is introducing two credit scores that incorporate buy-now, pay-later data, underscoring how significant a part of the consumer credit landscape the popular and controversial installment plans ...

CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on safety and efficacy, further data ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of 10% to 15% of their body weight, roughly in line with results from a ...

Scholar Rock (Nasdaq: SRRK) has unveiled encouraging Phase II data for its experimental therapy apitegromab, showing the drug can reduce the amount of lean mass lost during weight reduction with Eli ...

Telehealth: Leaders at Eli Lilly, which manufactures Zepbound and Mounjaro, said in June the company would work only with telehealth firms that stopped selling compounded versions of its GLP-1 ...